Literature DB >> 21161619

Factor VIII concentration is greater in female than male patients with HIV infection.

Alireza Abdollahi1, Afsaneh Morteza, Omid Khalilzadeh, Ahmad Ahmadzadeh.   

Abstract

The purpose of the present study was comparing plasma markers of coagulation between men and women in both HIV-infected patients and controls. Fifty-eight HIV-infected patients and 58 healthy participants who were individually matched with patients in age and sex were included in the study. We simultaneously collected blood samples for CD4+ T cell count, CD8+ T cell count, platelets count, hemoglobin, partial thromboplastin time (PTT), prothrombin time, international normalized ratio and blood type measurements. We used fresh plasma of the studied population to measure factor VIII, fibrinogen, antithrombin, protein C and protein S levels. CD4+ T cell count, CD8+ T cell count, platelet count, PTT, plasma fibrinogen, antithrombin, protein C and protein S levels were significantly lower, and plasma factor VIII levels were significantly higher in HIV patients. Factor VIII levels were significantly higher in HIV-infected women than HIV-infected men [200 (181-258) vs. 170 (150-194), p < 0.05]. This difference remained significant [219.7 (195.8-248.7) vs. 158 (136.5-180.3), p < 0.001] after multiple adjustments for age, CD8+ and CD4+ T cell count, using general linear model. Plasma factor VIII concentration was significantly higher in HIV-infected women after stratifying the patients into O, B, A and AB blood groups when there was not any gender difference in controls. We suggest that there is a sexual dimorphism in factor VIII concentration in HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21161619     DOI: 10.1007/s12185-010-0736-0

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  39 in total

1.  Sex difference in link between interleukin-6 and stress.

Authors:  Ryan Jankord; James R Turk; James C Schadt; Jennifer Casati; Venkataseshu K Ganjam; Elmer M Price; Duane H Keisler; M Harold Laughlin
Journal:  Endocrinology       Date:  2007-05-17       Impact factor: 4.736

2.  Progressive prothrombotic state in women with advancing HIV disease.

Authors:  Alexandra M Levine; Cheryl Vigen; Jay Gravink; Wendy Mack; C Heather Watts; Howard A Liebman
Journal:  J Acquir Immune Defic Syndr       Date:  2006-08-15       Impact factor: 3.731

3.  Major blood group antigens--a determinant of factor VIII levels in blood?

Authors:  D Mohanty; K Ghosh; N Marwaha; S Kaur; A P Chauhan; K C Das
Journal:  Thromb Haemost       Date:  1984-07-29       Impact factor: 5.249

4.  Biomarkers of hypercoagulability and inflammation in childhood-onset arterial ischemic stroke.

Authors:  Timothy J Bernard; Laura Z Fenton; Susan D Apkon; Richard Boada; Greta N Wilkening; C Corbett Wilkinson; Jennifer B Soep; Shelley D Miyamoto; Mark Tripputi; Jennifer Armstrong-Wells; Timothy A Benke; Marilyn J Manco-Johnson; Neil A Goldenberg
Journal:  J Pediatr       Date:  2009-12-21       Impact factor: 4.406

5.  Enhanced production of tumor necrosis factor-alpha and interleukin-6 due to prolonged response to lipopolysaccharide in human macrophages infected in vitro with human immunodeficiency virus type 1.

Authors:  A Bergamini; E Faggioli; F Bolacchi; S Gessani; L Cappannoli; I Uccella; F Demin; M Capozzi; R Cicconi; R Placido; S Vendetti; G M Colizzi; G Rocchi
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

6.  Relationship between progression to AIDS and thrombophilic abnormalities in HIV infection.

Authors:  Willem M Lijfering; Herman G Sprenger; Rita R Georg; Piet A van der Meulen; Jan van der Meer
Journal:  Clin Chem       Date:  2008-05-01       Impact factor: 8.327

7.  Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV-HCV coinfected patients.

Authors:  Joel Emery; Neora Pick; Edward J Mills; Curtis L Cooper
Journal:  Patient Prefer Adherence       Date:  2010-05-13       Impact factor: 2.711

8.  Thrombophilia in human immunodeficiency virus-infected patients with osteonecrosis: Is there a real connection? The first case-control study.

Authors:  Gabriela de Larrañaga; Edgardo Bottaro; Marta Martinuzzo; Raúl Figueroa; María Luisa Iglesias Varela; Silvia Perés Wingeyer; Ricardo Forastiero; Yolanda Adamczuk; Marcelo Corti; Liliana Puga; Jorge Benetucci
Journal:  Clin Appl Thromb Hemost       Date:  2007-12-26       Impact factor: 2.389

9.  Does patient sex affect human immunodeficiency virus levels?

Authors:  Monica Gandhi; Peter Bacchetti; Paolo Miotti; Thomas C Quinn; Fulvia Veronese; Ruth M Greenblatt
Journal:  Clin Infect Dis       Date:  2002-07-02       Impact factor: 9.079

10.  Venous thromboembolism in HIV-positive women during puerperium: a case series.

Authors:  J Marije Jansen; Willem M Lijfering; Herman G Sprenger; Jan van der Meer; Maria G van Pampus
Journal:  Blood Coagul Fibrinolysis       Date:  2008-01       Impact factor: 1.276

View more
  3 in total

1.  Association of hepatitis C with markers of hemostasis in HIV-infected and uninfected women in the women's interagency HIV study (WIHS).

Authors:  Elizabeth M Kiefer; Qiuhu Shi; Donald R Hoover; Robert Kaplan; Russell Tracy; Michael Augenbraun; Chenglong Liu; Marek Nowicki; Phyllis C Tien; Mardge Cohen; Elizabeth T Golub; Kathryn Anastos
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

2.  Thromboelastography on plasma reveals delayed clot formation and accelerated clot lyses in HIV-1 infected persons compared with healthy controls.

Authors:  Frederikke Falkencrone Rönsholt; Jan Gerstoft; Henrik Ullum; Pär Ingemar Johansson; Terese Lea Katzenstein; Sisse Rye Ostrowski
Journal:  BMC Infect Dis       Date:  2015-09-24       Impact factor: 3.090

3.  East Indian Sandalwood Oil Is a Phosphodiesterase Inhibitor: A New Therapeutic Option in the Treatment of Inflammatory Skin Disease.

Authors:  Manju Sharma; Corey Levenson; John C Browning; Emily M Becker; Ian Clements; Paul Castella; Michael E Cox
Journal:  Front Pharmacol       Date:  2018-03-09       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.